➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Dow
Express Scripts
AstraZeneca
Merck

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Squalene

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Squalene?

Squalene is an investigational drug.

There have been 12 clinical trials for Squalene. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2005.

The most common disease conditions in clinical trials are Hypercholesterolemia, Dyslipidemias, and Hyperlipoproteinemia Type II. The leading clinical trial sponsors are Takeda, Immune Design, and IDRI Corporation.

Recent Clinical Trials for Squalene
TitleSponsorPhase
A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the ToenailIQVIA BiotechPhase 2
A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the ToenailBlueberry TherapeuticsPhase 2
The Effects of GLA on Human VolunteersIDRI CorporationPhase 1

See all Squalene clinical trials

Clinical Trial Summary for Squalene

Top disease conditions for Squalene
Top clinical trial sponsors for Squalene

See all Squalene clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Dow
Express Scripts
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.